The simplest glycosphingolipids: a ceramide carrying exactly one sugar. Galactosylceramide is the brain's principal glycosphingolipid and myelin's largest single component, while glucosylceramide anchors the glycosphingolipid family — and each has a signature storage disease when its hydrolase fails.
Lipid Class
Glycosphingolipid (monoglycosylceramide)
Core Composition
Ceramide plus one hexose — glucose or galactose — at its 1-hydroxyl
Primary Location
Myelin; galactosylceramide reaches 12% of white-matter dry weight
Key Enzymes
Ceramide galactosyltransferase and glucosylceramide synthase build them; galactosylceramidase and glucocerebrosidase degrade them
Associated Conditions
Krabbe disease, Gaucher disease
Structure & Classification
Two types — glucosylceramide and galactosylceramide (gluco- and galactocerebroside) — differ by the sugar bound at the ceramide C-1 hydroxyl; sphingosine is the usual base.
Galactosylceramide reaches 2% of gray-matter dry weight and 12% of white matter; glucosylceramide sits at low levels in spleen, erythrocytes and neurons.
Glucosylceramide is the only glycosphingolipid common to plants, fungi and animals; the galactose variant is absent from plants.
Up to eight intermolecular hydrogen bonds give cerebrosides a melting point above body temperature; with cholesterol they pack into lipid rafts.
Biosynthesis & Metabolism
Each sugar arrives as a UDP-sugar; a glycosyltransferase transfers it to ceramide, inverting the linkage from alpha to beta.
Galactosylceramide is made on the lumenal surface of the endoplasmic reticulum; glucosylceramide on the cytosolic face of early Golgi membranes.
Turnover is lysosomal, splitting the molecule into fatty acids, sphingosine and free sugar — the sphingolipid metabolism branch that storage diseases block.
Cerebroside synthesis is a standard index of myelination and remyelination.
Physiological Role
Monogalactosylceramide is myelin's largest single component — the compact, hydrogen-bonded backbone of nerve insulation.
Glucosylceramide leads onward to the broader glycosphingolipid family, including the gangliosides; galactosylceramide, after sulfation, becomes myelin's sulfatides.
In epidermis, glucosylceramide is key to lamellar-body formation and the keratinocyte's water-permeability barrier.
Interactions
Myelin packs cerebrosides with cholesterol into raft domains as oligodendrocytes and Schwann cells wrap membrane.
When glucocerebrosidase fails, stored glucocerebroside swells macrophages into the paper-crumpled Gaucher cell.
Clinical Relevance
Gaucher disease, the commonest lysosomal storage disease: recessive GBA mutations strip glucocerebrosidase activity, so glucocerebroside accumulates in macrophages of spleen, liver and marrow — splenomegaly, anemia, bone disease. Birth incidence nears one in 450 among Ashkenazi Jews; enzyme replacement and substrate-reduction therapy (miglustat, eliglustat, which cut glucosylceramide formation) treat it; carriers carry roughly fivefold Parkinson risk.
Krabbe disease, about one in 100,000 births: galactosylceramidase deficiency (GALC, chromosome 14) lets psychosine build up, toxic to oligodendrocytes; globoid cells and demyelination follow, infantile onset inside six months, 60% one-year survival.